SCHEMBL1937002

SCHEMBL1937002

CCN(C)S(=O)(=O)Cc1cccc([N+](=O)[O-])c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 3/20 0.50
PYCR1 P32322 1/20 0.49
CYP3A4 P08684 1/20 0.47
LMNA P02545 2/20 0.44
KMT2A Q03164 4/20 0.44
GAA P10253 1/20 0.44
HTT P42858 1/20 0.44
CYP19A1 P11511 1/20 0.44
SIGMAR1 Q99720 1/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
ACHE P22303 1/20 0.42
CA2 P00918 1/20 0.42
CA5A P35218 1/20 0.42
CHRNB2 P17787 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4431155 0.88 CYP1A2 (0.57) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL2990041 0.87 TSHR (0.54) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL4435868 0.85 ALDH1A1 (0.55) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL10478654 0.84 MAOB (0.49) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL10499065 0.84 PYCR1 (0.51) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL1937393 0.83 TSHR (0.50) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL10478556 0.83 ALDH1A1 (0.45) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL10478714 0.82 TSHR (0.43) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL15686510 0.80 TSHR (0.57) CYP1A2CYP2C19CYP2D6CYP2C9TSHR
SCHEMBL10494303 0.80 CYP1A2 (0.49) CYP1A2CYP2C19CYP2D6CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines Bayer ScienceCrop AG (DE) 2011-09-22 US disclosed
EP-2330904-A2 4-ALKYL-SUBSTITUTED DIAMINOPYRIMIDINES Bayer CropScience AG (DE) 2011-06-15 EP disclosed
WO-2010025863-A2 4-ALKYL-SUBSTITUTED DIAMINOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines DPM1, DPYD, POLR1C CYP1A2 176/4885CYP2C19 499/4885CYP2D6 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.